glp 1 receptor agonists incretin mimetics GLP-1 or DPP-4 inhibitors: How to guide the clinician? Chemical structures of GLP-1 receptor
Description
Craig GG, Knox KW
Curr Top Behav Neurosci
Unlike opioid-based treatments, they do not carry risks of dependency
Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al
Lower interest rates have often supported stronger real estate returns and improved valuations
